Human insulin induces a higher glucagon response to induced hypoglycemia in short normal children, compared to porcine insulin

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 1, 1999, Pages 39-46

  Kanaka Gantenbein, Christina ^a   Catzeflis, Chantal ^a   Keller, Ulrich ^b   Fathi, Marc ^a   Theintz, Gerald E ^c   Sizonenko, Pierre Claude ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Centre Hospitalier Universitaire Vaudois   (Switzerland)

Author keywords

Catecholamines; Cortisol; Counterregulatory hormones; Glucagon; Growth hormone; Healthy children; Hypoglycemia; Insulin species

Indexed keywords

ADRENALIN; DOPAMINE; GLUCAGON; GROWTH HORMONE; HUMAN INSULIN; HYDROCORTISONE; NORADRENALIN; PIG INSULIN;

ADOLESCENT; ADRENALIN RELEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; HYPOGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORADRENALIN RELEASE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SHORT STATURE;

EID: 0032914430     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.1.39     Document Type: Article

References (25)

1. Teuscher A, Berger WG. Hypoglycemia unawareness in diabetics transferred from beef/porcine insulin to human insulin. Lancet 1987: ii: 382-385.
2. Berger W, Keller U, Honegger B, Jaeggi E. Warning symptoms of hypoglycemia during treatment with human and porcine insulin in diabetes mellitus. Lancet 1989; ii: 1041-1044.
3. Daneman D, Zinman B. Syndrome of hypoglycemia unawareness when changing insulin species. Diabetes Care 1991; 14: 145.
4. Everett J, Kerr D. Changing from porcine to human insulin. Drugs 1994; 47: 286-296.
5. Colagiuri S, Miller JJ, Petocz P. Double-blind cross-over comparison of human and porcine insulins in patients reporting lack of hypoglycemia awareness. Lancet 1992; 339: 1432-1435.
6. Schlüter KJ, Petersen KG, Sontheimer J, Enzmann F, Kerp L. Different counterregulatory responses to human insulin (recombinant DNA) and purified pork insulin. Diabetes Care 1982; 5 (Suppl 2): 78-81.
7. Patrick AW, Bodmer CW, Tieszen KL, White MC, Williams G. Human insulin and awareness of acute hypoglycemic symptoms in insulin-dependent diabetes. Lancet 1991; 338: 528-532.
8. Lingenfelser T, Renn W, Plonz C, Radjaipour M, Eggstein M, Jakober B. Catecholamine response during human and pork insulin-induced hypoglycemia in IDDM patients. Diabetes Care 1992; 15: 261-264.
9. Ferrer JP, Esmatjes E, Gonzalez-Clemente JM, Goday A, Conget I, Jimenez W, Gomis R, Rivera F, Vilardell E. Symptomatic and hormonal hypoglycemic responses to human and porcine insulin in patients with type I diabetes mellitus. Diabet Med 1992; 9: 522-527.
10. Lingenfelser T, Pickert A, Pfohl M, Renn W, Radjaipour M, Collet C, Eggstein M, Jakober B. Hypothalamic-pituitary activation does not differ during human and porcine insulin-induced hypoglycemia in insulin-dependent diabetes mellitus. Clin Invest 1993; 72: 56-59.
11. Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med 1987; 316: 1376-1383.
12. Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994; 43: 1426-1434.
13. Heine RJ, van der Heyden EAP, van der Veen EA. Responses to human and porcine insulin in healthy subjects. Lancet 1989; ii. 946-948.
14. Jones TW, Caprio S, Diamond MP, Hallarman L, Boulware SD, Sherwin RS, Tamborlane WV. Does insulin species modify counterregulatory hormone response to hypoglycemia? Diabetes Care 1991; 14: 728-731.
15. LeRoith D, Shemer J, Pickens W, Leslie N, Sperling M. Berelowitz M. Comparison of the counterregulatory hormone response to semisynthetic human insulin and purified porcine insulin in normal subjects and patients with type I diabetes mellitus. Clin Ther 1991; 13: 613-626.
16. Jones TW, Borg WP, Boulware SD, McCarthy G, Sherwin RS, Tamborlane WV. Enhanced adreno-medullary response and increased susceptibility to neuroglycopenia: Mechanisms underlying the adverse effects of sugar ingestion in healthy children. J Pediatr 1995; 126: 171-177.
17. Zuppinger K, Aebi C, Fankhauser S, Herz G, Zurbrügg RP, Schopfer K, Neri TM. Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus. Diabetologia 1987; 30: 912-915.
18. Zuppinger K, Egger M, Aebi Ch, Schoenle E, Gschwend-Eigenmann S, Mullis P. Hypoglykämien bei Kindern mit Diabetes unter humanem oder porcinem Insulin. Schweiz Med Wschr 1989; 119: 532-535.
19. Root AW, Rosenfield RL, Bongiovanni AM, Eberlein WR. The plasma growth hormone response to insulin-induced hypoglycemia in children. Pediatrics 1967; 39: 844-852.
20. Holst JJ, Aasted B. Production and evaluation of glucagon antibodies for radioimmunoassay. Acta Endocrinol 1974; 77: 715-726.
21. Gerich GE, Langlois M, Noacco C, Karam JH, Forsham PH. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 1973; 182: 171-173.
22. Bolli G, Calabrese G, De Feo P, Compagnucci P. Zega G, Angeletti G, Cartechini MG, Santeusanio F, Brunetti P. Lack of glucagon response in glucose counter-regulation in type I (insulin dependent) diabetics: Absence of recovery after prolonged optimal insulin therapy. Diabetologia 1982; 22: 100-105.
23. Brambilla P, Bougnères PF, Santiago JV, Chaussain JL, Pouplard A, Castano L. Glucose counterregulation in pre-school-age diabetic children with recurrent hypoglycemia during conventional treatment Diabetes 1987; 36: 300-304.
24. Rizza RA, Raymond M, Cryer R. Gerich JE. Role of glucagon, catecholamines and growth hormone in human glucose counterregulation. J Clin Invest 1979; 64: 62-71.
25. De Feo P, Perriello G, Torlone E, Fanelli C, Ventura MM, Santeusanio F, Brunetti P, Gerich JE. Bolli GB. Evidence against important catecholamine compensation for absent glucagon counterregulation. Am J Physiol 1991; 260: E203-E212.